NINDS Advisory Council Agenda - September 7, 2017

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health

National Institute of Neurological Disorders and Stroke

 

National Advisory Neurological Disorders and Stroke Council

200th Meeting

September 7, 2017

Building 35, Porter Neuroscience Research Center, Conference Room 620/630/640

35 Convent Drive

Bethesda, Maryland 20892

NIH Videocast Website: http://videocast.nih.gov/

 

AGENDA

September 7, 2017

OPEN SESSION

 

8:00 a.m.

I.          Call to Order and Opening Remarks  

Dr. Robert Finkelstein, Executive Secretary, NANDS Council

8:05 a.m.

II.        Report of the Director, Division of Extramural Activities, NINDS

Dr. Robert Finkelstein

  1. Consideration of Minutes of May 18, 2017, Meeting

            B.     Confirmation of Dates for Future Council Meetings

                                                February 1-2, 2018                 (Thursday and Friday)

                                                May 24-25, 2018                    (Thursday and Friday)

                                                September 13-14, 2018           (Thursday and Friday)

                                                February 7-8, 2019                 (Thursday and Friday)

                                                May 9-10, 2019                      (Thursday and Friday)

                                                September 5-6, 2019               (Thursday and Friday)

C.     Other Items

           Expedited Review Process

           Extramural Announcements

8:15 a.m.

III.       National Academies Report "Preventing Cognitive Decline and Dementia: A Way

            Forward"

Dr. Story Landis, Director Emeritus, NINDS

Dr. Alan Leshner, CEO Emeritus, American Association for the Advancement of Science, Director Emeritus, NIDA

9:00 a.m.

BREAK

9:15 a.m.

IV.       Report of the Director, NINDS

Dr. Walter Koroshetz, Chairperson

10:30 a.m.

V.        A Perspective on Diversity

Dr. Eric Nestler, President, Society for Neuroscience, Director, Friedman Brain Institute, Icahn School of Medicine, Mount Sinai

11:15 a.m.

VI.       Update on NINDS Programs for Enhancing Diversity in Neuroscience Research

Dr. Michelle Jones-London, Office of Programs to Enhance Neuroscience Workforce Diversity (OPEN-WD), NINDS

12:15 p.m.

LUNCH

1:15 p.m.

VII.     Initiative Requiring Concept Clearance:

A “Fit for Purpose” NINDS Biomarker Strategy: Discovery through Development

Dr. Mary Ann Pelleymounter, Division of Translational Research, NINDS

1:45 p.m.

VIII.    Proposed Changes to the Special Council Review (SCR) Process

Dr. Robert Finkelstein

2:45 p.m.

BREAK

3:00 p.m.

CLOSED SESSION

This portion of the meeting is being closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5, U.S. Code and Section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2).

 

IX.       Review of Conflict of Interest, Confidentiality, and Council Procedures

            Council Consideration of Pending Applications  

            Dr. Robert Finkelstein 

5:00 p.m. **

ADJOURNMENT